Why the study?
Non-physiological blood pressure circadian patterns increase cardiovascular risk, but their association with glucometabolic phenotypes during oral glucose tolerance testing was unclear.
Does a 1-h post-load glucose ≥ 155 mg/dL during an oral glucose tolerance test associate with a pathological non-dipping blood pressure pattern in newly diagnosed hypertensive patients?
Does a 1-h post-load glucose ≥ 155 mg/dL during an oral glucose tolerance test associate with a pathological non-dipping blood pressure pattern in newly diagnosed hypertensive patients?
In newly diagnosed hypertensive patients, a 1-h post-load glucose ≥ 155 mg/dL during an oral glucose tolerance test is significantly associated with a pathological non-dipping nocturnal blood pressure pattern, indicating a higher cardiovascular risk profile.
May flag higher CV risk in new hypertensives; hypothesis-generating and leaves open prospective validation.
It is known that, a not physiological blood pressure (BP) circadian pattern has been associated with increased risk of organ damage and cardiovascular (CV) event. The aim of this study was to assess the association between circadian BP pattern and glucometabolic phenotypes occurring after oral glucose tolerance test (OGTT). We recruited 810 hypertensive Caucasian patients. All participants underwent to OGTT, laboratory test and 24-h ambulatory BP monitoring (ABPM). The analysis of collected data allowed classifying patients based on nocturnal BP profiles into four categories: dippers, non-dippers, extreme dippers, and reverse dippers. Considering the dipping pattern, the proportion of non-dippers in normal glucose tolerance patients with 1-h glucose ≥ 155 mg/dL (NGT ≥ 155) (36.4%) was higher than NGT < 155 (29.6%) and impaired glucose tolerance (IGT) (34.8%), but lower than type 2 diabetes group (T2DM) (52.6%) (p = 0.001). The proportion of dippers was lower in NGT ≥ 155 (47%) and T2DM (34.6%), when compared with NGT < 155 (53.8%) and IGT (51.2%) (p = 0.017). From logistic regression analysis, 1-h glucose ≥ 155 increased the risk of a pathological nocturnal drop in BP by 74%, (OR = 1.740, 95% CI 1.254-2.415, p < 0.0001). In addition, the improvement in 1 unit of Matsuda was responsible for a 3.5% risk decrease (OR = 0.965, 95% CI 0.958-0.971, p < 0.0001), while e-GFR determined a 0.9% risk reduction of nocturnal BP drop (OR = 0.991, 95% CI 0.984-0.999, p = 0.020). Our data demonstrated the existence, in newly diagnosed hypertensive patients, of an association between circadian BP profile and altered glycemic response during OGTT, in particular NGT ≥ 155 subjects are associated with a non-dipper BP pattern, this is clinically relevant because may explain, at least in part, the increased CV risk in this setting of patients.
No takes yet. Share an insight, caveat, or question.
Condoleo et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: